Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microbiome Rehabilitation After Antibiotics
NCT03218579Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Feb 2013
- Primary completion
- Dec 2019
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Randomised, open-label trial of fecal microbiome transplant (3 arms), sponsored by Tel Aviv Sourasky Medical Center. Primary endpoint: Microbiome composition at 1 year. Status: unknown.
02
Drugs
fecal microbiome transplant
Beyond the preview
Go deeper on NCT03218579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03218579.